De Nys, L.; Barzegar-Fallah, A.; Lanckmans, K.; Steurbaut, S.; Beckwée, D.; de Haar-Holleman, A.; Provyn, S.; Gasthuys, E.; Vande Casteele, S.; De Sutter, P.-J.;
et al. Dose-Limiting Toxicities of Paclitaxel in Breast Cancer Patients: Studying Interactions Between Pharmacokinetics, Physical Activity, and Body Composition—A Protocol for an Observational Cohort Study. Cancers 2025, 17, 50.
https://doi.org/10.3390/cancers17010050
AMA Style
De Nys L, Barzegar-Fallah A, Lanckmans K, Steurbaut S, Beckwée D, de Haar-Holleman A, Provyn S, Gasthuys E, Vande Casteele S, De Sutter P-J,
et al. Dose-Limiting Toxicities of Paclitaxel in Breast Cancer Patients: Studying Interactions Between Pharmacokinetics, Physical Activity, and Body Composition—A Protocol for an Observational Cohort Study. Cancers. 2025; 17(1):50.
https://doi.org/10.3390/cancers17010050
Chicago/Turabian Style
De Nys, Len, Anita Barzegar-Fallah, Katrien Lanckmans, Stephane Steurbaut, David Beckwée, Amy de Haar-Holleman, Steven Provyn, Elke Gasthuys, Sofie Vande Casteele, Pieter-Jan De Sutter,
and et al. 2025. "Dose-Limiting Toxicities of Paclitaxel in Breast Cancer Patients: Studying Interactions Between Pharmacokinetics, Physical Activity, and Body Composition—A Protocol for an Observational Cohort Study" Cancers 17, no. 1: 50.
https://doi.org/10.3390/cancers17010050
APA Style
De Nys, L., Barzegar-Fallah, A., Lanckmans, K., Steurbaut, S., Beckwée, D., de Haar-Holleman, A., Provyn, S., Gasthuys, E., Vande Casteele, S., De Sutter, P.-J., Vermeulen, A., Van Bocxlaer, J., Wuyts, S. C. M., & Adriaenssens, N.
(2025). Dose-Limiting Toxicities of Paclitaxel in Breast Cancer Patients: Studying Interactions Between Pharmacokinetics, Physical Activity, and Body Composition—A Protocol for an Observational Cohort Study. Cancers, 17(1), 50.
https://doi.org/10.3390/cancers17010050
